DocMeetings

There is significant interest in the role of B cells in cancer. With an increasing demand for antibody and cell-based therapeutics, a deeper understanding of the immune system and cancer genomics has become more crucial than ever. By studying B cells and immune repertoires, researchers are able to discover more nuanced and targeted therapies against cancer.

Join industry experts Dr. Dmitriy M. Chudakov, CSO at MiLaboratories LLC, and Dr. Nicola Bonzanni, CSO at ENPICOM, for an in-depth discussion on what we can learn from B cells and antibody repertoires to advance cell and gene therapies. The speakers will highlight recent advancements in B cell research and cutting-edge software solutions for analyzing antibody repertoires.

Attend this webinar to explore:
– Roles of B cells in cancer
– The use of antibody repertoires in tumor samples
– How to address challenges of intratumoral clonal heterogeneity
– The use of cutting-edge technologies to leverage the full potential of antibody sequencing data


Get all these insights and more with this 45-minute session followed by a live Q&A.